Critical Review: Acadia Healthcare (ACHC) and The Competition
Acadia Healthcare (NASDAQ: ACHC) is one of 49 public companies in the “Healthcare Facilities & Services” industry, but how does it compare to its competitors? We will compare Acadia Healthcare to related companies based on the strength of its institutional ownership, earnings, dividends, analyst recommendations, valuation, risk and profitability.
Insider & Institutional Ownership
73.5% of shares of all “Healthcare Facilities & Services” companies are held by institutional investors. 11.1% of Acadia Healthcare shares are held by company insiders. Comparatively, 12.8% of shares of all “Healthcare Facilities & Services” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Valuation and Earnings
This table compares Acadia Healthcare and its competitors gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Acadia Healthcare||$2.83 billion||$574.61 million||477.33|
|Acadia Healthcare Competitors||$5.72 billion||$906.68 million||37.08|
Acadia Healthcare’s competitors have higher revenue and earnings than Acadia Healthcare. Acadia Healthcare is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Risk & Volatility
Acadia Healthcare has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Comparatively, Acadia Healthcare’s competitors have a beta of 1.01, indicating that their average stock price is 1% more volatile than the S&P 500.
This is a summary of current ratings and recommmendations for Acadia Healthcare and its competitors, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Acadia Healthcare Competitors||184||1257||1787||31||2.51|
Acadia Healthcare currently has a consensus price target of $56.56, indicating a potential upside of 31.65%. As a group, “Healthcare Facilities & Services” companies have a potential downside of 2.13%. Given Acadia Healthcare’s stronger consensus rating and higher possible upside, equities analysts plainly believe Acadia Healthcare is more favorable than its competitors.
This table compares Acadia Healthcare and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Acadia Healthcare Competitors||6.93%||0.33%||0.51%|
Acadia Healthcare beats its competitors on 7 of the 13 factors compared.
About Acadia Healthcare
Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities. The Company is engaged in operating acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers and facilities providing outpatient behavioral healthcare services. As of December 31, 2016, the U.S. Facilities segment included 208 behavioral healthcare facilities with approximately 8,500 beds in 39 states and Puerto Rico, and the U.K. Facilities segment included 365 behavioral healthcare facilities with approximately 8,600 beds in the United Kingdom. As of December 31, 2016, the Company had operated 573 behavioral healthcare facilities with approximately 17,100 beds in 39 states, the United Kingdom and Puerto Rico.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.